Clinical trial
Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced…
NCT00148291 · West Japan Thoracic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00148291 |
|---|---|
| Title | Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer |
| Official title | Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | West Japan Thoracic Oncology Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Patients were randomized to receive either docetaxel 60 mg/m2 on day 1 or vinorelbine 25 mg/m2 on days 1and 8, repeated every 21 days over four cycles. |
| Enrollment | 180 |
| Start date | Jun 1, 1999 |
| First posted | Sep 7, 2005 |
| Last update posted | Jan 6, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: